Arising International

Arising International (Holdings) Limited is a strategic investment and holding company within the healthcare sector, operating as a key subsidiary of Grand Pharmaceutical Group. The company focuses on expanding its parent organization's global footprint through international acquisitions, licensing, and strategic partnerships in high-growth areas such as oncology, radiopharmaceuticals, and ophthalmology. It played a pivotal role in the landmark $1.4 billion acquisition of Sirtex Medical, a global leader in liver cancer-targeted therapies. Additionally, Arising International manages significant investments and collaborations with biotechnology firms like OncoSec Medical and ITM (Isotopes Technologies Munich). Through these activities, the company facilitates the introduction of innovative medical technologies and advanced therapeutic solutions into the Chinese and international markets.